Share This

Related Topics News -

     
 Detail   |   Print    Next page > 
     
君聖泰醫藥(02511.HK)治療代謝及消費系統藥物臨床試驗達主要終點
2025-04-15T  
《業績》君聖泰醫藥(02511.HK)去年虧損收窄至3.82億人幣 不派息
2025-03-28T  
君聖泰醫藥(02511.HK)治療代謝及消化系統疾病藥物臨床試驗完成患者入組
2025-01-02T  
君聖泰醫藥(02511.HK)與石四藥(02005.HK)訂立戰略合作框架協議
2024-12-19T  
石四藥集團(02005.HK)附屬與君聖泰醫藥-B(02511.HK)子公司訂立框架協議
2024-12-19T  
君聖泰醫藥(02511.HK)更換核數師
2024-12-12T  
《業績》君聖泰醫藥-B(02511.HK)半年虧損收窄至2.11億元人民幣
2024-08-28T  
君聖泰醫藥(02511.HK)擬於河北滄州設立生產原材料營運主體基地
2024-07-02T  
君聖泰醫藥(02511.HK)HTD1801臨床試驗完成患者入組
2024-06-28T  
君聖泰醫藥(02511.HK)不悉股價波動原因 確認業務營運正常
2024-06-25T  
  Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2025 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.